Autologous Transplantation as Consolidation for High Risk Aggressive T-Cell Non-Hodgkin's Lymphoma: A SWOG 9704 Intergroup Trial Subgroup Analysis

Phase II data suggest a benefit to autotransplantation for aggressive T-NHL in first remission; randomized trials have yet to validate this. We performed a retrospective analysis of aggressive T-NHL patients in the intergroup randomized consolidative autotransplant trial (SWOG 9704). Of the 370 enro...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Leuk Lymphoma
Главные авторы: Al-Mansour, Zeina, Li, Hongli, Cook, James R., Constine, Louis S., Couban, Stephen, Stewart, Douglas A., Shea, Thomas C., Porcu, Pierluigi, Winter, Jane N., Kahl, Brad S., Smith, Sonali M., Marcellus, Deborah C., Barton, Kevin P., Mills, Glenn M., LeBlanc, Michael, Rimsza, Lisa M., Forman, Stephen J., Leonard, John P., Fisher, Richard I., Friedberg, Jonathan W., Stiff, Patrick J.
Формат: Artigo
Язык:Inglês
Опубликовано: 2019
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6620162/
https://ncbi.nlm.nih.gov/pubmed/30628511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2018.1563691
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы